Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Lixivaptan> ?p ?o. }
Showing items 1 to 46 of
46
with 100 items per page.
- Lixivaptan abstract "Lixivaptan (VPA-985) is a phase III pharmaceutical being developed by Cardiokine, Inc., a specialty pharmaceutical company based in Philadelphia, PA, focused on the development of pharmaceuticals for the treatment and prevention of cardiovascular diseases. Lixivaptan is, as of May 2010, in Phase III clinical trials involving patients with hyponatremia, including those with concomitant heart failure. Hyponatremia is an electrolyte disturbance in which the sodium concentration in the serum is lower than normal. Lixivaptan may help some patients eliminate excess fluids while retaining electrolytes.".
- Lixivaptan atcPrefix "none".
- Lixivaptan casNumber "168079-32-1".
- Lixivaptan fdaUniiCode "8F5X4B082E".
- Lixivaptan iupacName "N-[3-chloro-4-(5H-pyrrolo-[2,1-c][1,4]benzodiazepin-".
- Lixivaptan pubchem "172997".
- Lixivaptan thumbnail Lixivaptan.png?width=300.
- Lixivaptan wikiPageID "20700983".
- Lixivaptan wikiPageRevisionID "545519396".
- Lixivaptan atcPrefix "none".
- Lixivaptan c "27".
- Lixivaptan casNumber "168079".
- Lixivaptan chembl "49429".
- Lixivaptan cl "1".
- Lixivaptan f "1".
- Lixivaptan h "21".
- Lixivaptan hasPhotoCollection Lixivaptan.
- Lixivaptan iupacName "N-[3-chloro-4-".
- Lixivaptan molecularWeight "473.926".
- Lixivaptan n "3".
- Lixivaptan o "2".
- Lixivaptan pubchem "172997".
- Lixivaptan unii "8".
- Lixivaptan verifiedfields "changed".
- Lixivaptan verifiedrevid "458621315".
- Lixivaptan width "200".
- Lixivaptan subject Category:Drugs_acting_on_the_cardiovascular_system.
- Lixivaptan type Agent114778436.
- Lixivaptan type CausalAgent100007347.
- Lixivaptan type Drug103247620.
- Lixivaptan type DrugsActingOnTheCardiovascularSystem.
- Lixivaptan type Matter100020827.
- Lixivaptan type PhysicalEntity100001930.
- Lixivaptan type Substance100020090.
- Lixivaptan type Drug.
- Lixivaptan type DrugProduct.
- Lixivaptan type FunctionalSubstance.
- Lixivaptan comment "Lixivaptan (VPA-985) is a phase III pharmaceutical being developed by Cardiokine, Inc., a specialty pharmaceutical company based in Philadelphia, PA, focused on the development of pharmaceuticals for the treatment and prevention of cardiovascular diseases. Lixivaptan is, as of May 2010, in Phase III clinical trials involving patients with hyponatremia, including those with concomitant heart failure.".
- Lixivaptan label "Lixivaptan".
- Lixivaptan sameAs m.051x3sv.
- Lixivaptan sameAs Q6659958.
- Lixivaptan sameAs Q6659958.
- Lixivaptan sameAs Lixivaptan.
- Lixivaptan wasDerivedFrom Lixivaptan?oldid=545519396.
- Lixivaptan depiction Lixivaptan.png.
- Lixivaptan isPrimaryTopicOf Lixivaptan.
